𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Can chronic subthalamic nucleus stimulation induce de novo tremor in Parkinson's disease?

✍ Scribed by Stephane Thobois; Stephen Tisch; Jing Xie-Brustolin; Patrick Mertens; Marwan I. Hariz; Isabelle Benatru; Emmanuel Broussolle; Patricia Limousin-Dowsey

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
58 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Subthalamic nucleus stimulation dramatically improves parkinsonian symptoms, notably the tremor. The occurrence of a tremor in the first 6 months after the surgical procedure in patients without tremor preoperatively is much less common. We report on the cases of 3 patients who developed such modification of their parkinsonian symptomatology. Physiopathological hypotheses are discussed. © 2005 Movement Disorder Society

📜 SIMILAR VOLUMES

Pathological gambling in Parkinson's dis
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
✍ Claire Ardouin; Valerie Voon; Yulia Worbe; Nehman Abouazar; Virginie Czernecki; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract Pathological gambling (PG) related to dopaminergic treatment in Parkinson's disease (PD) is part of a spectrum of behavioral disorders called the dopamine dysregulation syndrome (DDS). We describe a series of PD patients with preoperative active PG due to dopaminergic treatment from a t

Subthalamic nucleus stimulation restores
Subthalamic nucleus stimulation restores corticospinal facilitation in Parkinson's disease
✍ Monika Pötter-Nerger; Tihomir V. Ilic; Hartwiq R. Siebner; Günther Deuschl; Jens 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract We have previously shown that in patients with Parkinson's disease (PD), high‐frequency stimulation (HFS) of the subthalamic nucleus (STN) modifies spinal excitability via subcortical reticulospinal routes. To investigate whether STN‐HFS also modifies spinal excitability via transcortic

Subthalamic nucleus deep brain stimulati
Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease
✍ Michelle R. Ciucci; Julie M. Barkmeier-Kraemer; Scott J. Sherman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract Relatively little is known about the role of the basal ganglia in human deglutition. Deep brain stimulation (DBS) affords us a model for examining deglutition in humans with known impairment of the basal ganglia. The purpose of this study was to examine the effects of subthalamic nuclei

Subthalamic nucleus stimulation affects
Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease
✍ Tereza Serranová; Robert Jech; Petr Dušek; Tomáš Sieger; Filip Růžička; Dušan Ur 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Abstract Deep brain stimulation (DBS) of the subthalamic nucleus (STN) can induce nonmotor side effects such as behavioral and mood disturbances or body weight gain in Parkinson's disease (PD) patients. We hypothesized that some of these problems could be related to an altered attribution of inc

Addiction in Parkinson's disease: Impact
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
✍ Tatiana Witjas; Christelle Baunez; Jean Marc Henry; Marie Delfini; Jean Regis; A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering fro

Postoperative gait deterioration after b
Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease
✍ Bart F.L. van Nuenen; Rianne A.J. Esselink; Marten Munneke; Johhannes D. Speelma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Deep brain stimulation of the subthalamic nuclei (STN) is a good therapeutic option to reduce dyskinesias and improve appendicular motor signs in well‐selected patients with advanced Parkinson's disease (PD). Concerns about long‐term adverse effects play an increasingly role in the deci